1. Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review

   • Georgia E. Ritchie
   • Mangalee Fernando
   • David Goldstein

   Review Article 06 August 2016 Pages: 1 - 7

   

2. Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial

   • Michel Ducreux
   • Jaafar Bennouna
   • Alfredo Romano

   Original Article 19 November 2016 Pages: 9 - 16

   

3. A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors

   • James Spicer
   • Sheeba Irshad
   • Johann de Bono

   Original Article Open access 21 November 2016 Pages: 17 - 27

   

4. Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)

   • Masato Nakamura
   • Toru Aoyama
   • Hideyuki Mishima

   Original Article Open access 22 November 2016 Pages: 29 - 36

   

5. Survival impact of neoadjuvant gemcitabine plus S-1 chemotherapy for patients with borderline resectable pancreatic carcinoma with arterial contact

   • Yoshiaki Murakami
   • Kenichiro Uemura
   • Taijiro Sueda

   Original Article 22 November 2016 Pages: 37 - 47

   

6. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma

   • Hui Zhang
   • Yan Guo
   • Chao Shang

   Original Article 22 November 2016 Pages: 49 - 55

   

7. Etirinotecan pegol administration is associated with lower incidences of neutropenia compared to irinotecan administration

   • S. Kenneth Sy
   • Theresa D. Sweeney
   • Michael A. Eldon

   Original Article Open access 30 November 2016 Pages: 57 - 67

   

8. Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway

   • Ming-ming He
   • Dong-sheng Zhang
   • Rui-hua Xu

   Original Article Open access 02 December 2016 Pages: 69 - 79

   

9. Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma

   • Sung Won Lee
   • Hae Lim Lee
   • Seung Kew Yoon

   Original Article 02 December 2016 Pages: 81 - 88

   

10. A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors

    • Toshihiko Doi
    • Nozomu Fuse
    • Atsushi Ohtsu

    Original Article Open access 03 December 2016 Pages: 89 - 98

    

11. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas

    • Young Saing Kim
    • Sung Yong Oh
    • Joung-Soon Jang

    Original Article 07 December 2016 Pages: 99 - 106

    

12. Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer

    • Takayuki Yoshino
    • Ichinosuke Hyodo
    • Narikazu Boku

    Original Article 08 December 2016 Pages: 107 - 116

    

13. Synergistic disruption of ERα/HER2 crosstalk by endoxifen and lapatinib in breast cancer cells

    • James Chun Yip Chan
    • Pei Shi Ong
    • Eric Chun Yong Chan

    Original Article 09 December 2016 Pages: 117 - 130

    

14. LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer

    • Shunji Takahashi
    • Takayuki Kobayashi
    • Taito Esaki

    Original Article Open access 09 December 2016 Pages: 131 - 138

    

15. Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor

    • Changhoon Yoo
    • Hyungwoo Cho
    • Baek-Yeol Ryoo

    Original Article 10 December 2016 Pages: 139 - 146

    

16. Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)

    • Hironaga Satake
    • Masaaki Iwatsuki
    • Kyushu Study Group of Clinical Cancer

    Original Article Open access 10 December 2016 Pages: 147 - 153

    

17. A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma

    • Margarita B. Belogurova
    • Zoryana P. Kizyma
    • Andreas Lammerich

    Original Article Open access 16 December 2016 Pages: 155 - 164

    

18. Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer

    • Kyoichi Kaira
    • Yoshio Tomizawa
    • Takeshi Hisada

    Original Article 19 December 2016 Pages: 165 - 171

19. Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma

    • Ji Young Lee
    • Cheryn Song
    • Jae Lyun Lee

    Original Article 23 December 2016 Pages: 173 - 180

    

20. First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium

    • Frank M. Balis
    • Patrick A. Thompson
    • Elizabeth Fox

    Original Article Open access 28 December 2016 Pages: 181 - 187

    

21. Population pharmacokinetics of lenalidomide in multiple myeloma patients

    • Beatriz Guglieri-López
    • Alejandro Pérez-Pitarch
    • Matilde Merino-Sanjuán

    Original Article 30 December 2016 Pages: 189 - 200

    

22. Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies

    • Charles A. Kunos
    • Edward Chu
    • S. Percy Ivy

    Clinical Trial Report 22 November 2016 Pages: 201 - 207

23. Successful afatinib treatment of advanced non-small-cell lung cancer patients undergoing hemodialysis

    • Hisao Imai
    • Kyoichi Kaira
    • Masanobu Yamada

    Short Communication 29 November 2016 Pages: 209 - 213

    

24. Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure

    • Kim Dao
    • Yimin Lu
    • Sebastien Kissling

    Short Communication 17 December 2016 Pages: 215 - 218